240-286-6 | Sigma-Aldrich

Data Sheet - C6395 - Lot 71K8805

180 200 220 240 260 280 300 320 0 10000 20000 30000 40000 50000 60000 m/z Abundance 43 55 67 77 91 107 121 147 159 174 193 207 231 246

Product Information Sheet - L2023

(Tokyo), 22(6), 283-286 (1969). 4. Zimmerman, U-J.P. and Schlaepfer, W.W., Biochemistry, 21(17), 3977-3983 (1982). 5. Knight, C.G., Biochem. J., 189(3), 447-453 (1980). 6. Zollner, H.

Complement C7 Deficient Serum (C1413)

al., J. Immunol., 121, 484 (1978). 2. Götze, O., and Müller-Eberhard, H.J., N. Engl. J. Med., 286, 180 (1972). RBG,MAM 06/09-1 Table 1. The volumes indicated are an example only. Adjust the volumes

Quality Control Range Sheet- A6041-102and A6041-202

/mL IL-2 Control 1 27 - 56 pg/mL IL-5 Control 1 67 - 140 pg/mL Control 2 138 - 286 pg/mL Control 2

XP725 Antibody Number-Lot Number 071M4826

211 212 233 234 235 236 257 258 259 260 281 282 283 284 3.6 213 214 215 216 237 238 239 240 261 262 263 264 285 286 287 288 4.1 289 290 291 292 313 314 315 316 337 338

Viral filtration of plasma-derived human IgG

, Washington DC (2002.) 15. A.J. DiLeo, D.A. Vacante and E.F. Deane, Biologicals 21, 275–286. (1993). 16. Millipore Application Note, Ensuring Regulatory Compliance: Validation of Virus

Reprint: Viral Filtration of Plasma-Derived Human IgG: A Case Study using Viresolve® NFP

Planova Workshop, Washington, DC, 2002. 15.DiLeo AJ, Vacante DA, Deane EF, Biologicals. 1993; 21:275-286. 16.Millipore Application Note, Ensuring Regulatory Compliance: Validation of Virus Filtration, AN1650EN00

Brochure: Ascentis® Express Fused-Core® HPLC and UHPLC Columns

0 2 4 6 Min 1 2 3 4 5 6 78 9 10 11 12 13 1. Morphine (m/z 286) 2. Oxymorphone (m/z 302) 3. Hydromorphone (m/z 286) 4. Naloxone (m/z

Material Matters Vol. 1, No. 1

Avgeropoulos, A. et al. Chem. Mater. 1998, 10, 2109. (8) Chan, V. Z.-H. et al. L. Science 1999, 286, 1716. (9) Matyjaszewski, K. Advances in Controlled/Living Radical Polymerization; American Chemical

MAPK: Antibodies, Proteins, Kits, siRNA and Reagents

length Pur E. coli 20 µg SGT211 12 Assay cdc42 Activation Assay Kit ABA 1 kit 17-286 Anti-cdc42 Immunoblotting Kit WB 1 kit 17-299 Cdc42/Rac Activation Assay

XP725 Antibody List Lot 129K4831

ROCK-2 R8653 9475 ROCK2 P NP_004841.2 y y n/d 702 Syntaxin 8 S8945 9482 STX8 P NP_004844.1 n/d n/d y 286 FXR2 F1554 9513 FXR2 M NP_004851.2 y n/d n/d 525 p130CAS C0354 9564 BCAR1 P NP_001164185.1 y y y 445

XP725 Antibody List Lot 129K4830

ROCK-2 R8653 9475 ROCK2 P NP_004841.2 y y n/d 702 Syntaxin 8 S8945 9482 STX8 P NP_004844.1 n/d n/d y 286 FXR2 F1554 9513 FXR2 M NP_004851.2 y n/d n/d 525 p130CAS C0354 9564 BCAR1 P NP_001164185.1 y y y 445

XP725 Antibody List Lot 089K4791

ROCK-2 R8653 9475 ROCK2 P NP_004841.2 y y n/d 702 Syntaxin 8 S8945 9482 STX8 P NP_004844.1 n/d n/d y 286 FXR2 F1554 9513 FXR2 M NP_004851.2 y n/d n/d 525 p130CAS C0354 9564 BCAR1 P NP_001164185.1 y y y 445

XP725 Worksheet for Lot Number 071M4826

pSer45 C5615 283 2 2 6 3 bCatenin pSer33 C2363 284 2 2 6 4 bCatenin pSer33 C2363 dCatenin NPRAP C4864285 2 2 6 5 286 2 2 6 6 dCatenin NPRAP C4864 287 2 2 6 7 Anti CY3/5 C0992 288 2 2

List of Antibodies

C-Terminal F9925 P y y n/d 283 FOXC2 F1054 P y y n/d 284 FOXP2 F6304 P y y y 285 FANCD2 F0305 P y y y 286 FXR2 F1554 M y n/d n/d 287 FRS2 (SNT-1) F9052 P y y y 288 Anti Cy3+Cy5 C0992

Halal Certificate

FG W320501 B80093 HC-23SIF602 285. 4-METHYL-5-THIAZOLEETHANOL FG W320404 A45808 HC-23SI4849 286. 4-METHYL-5-VINYLTHIAZOLE 97%, FG W331309 A77976 HC-23SITZ80 287. 4-METHYLANISOLE 99%, FCC, FG W268100

Halal Certificate

FG W320501 B80093 HC-22SI7623 285. 4-METHYL-5-THIAZOLEETHANOL FG W320404 A45808 HC-22SIVG70 286. 4-METHYL-5-VINYLTHIAZOLE 97%, FG W331309 A77976 HC-22SI6T02 287. 4-METHYLANISOLE 99%, FCC, FG W268100

XP725 Antibody List 013M4793

114142 Foxp2,FOXP2 NP_683697.1,NP_997600.1 P y y y 285 FANCD2 F0305 2177 FANCD2 NP_149075.2 P y y y 286 FXR2 F1554 9513 FXR2 NP_004851.1 M y n/d n/d 287 FRS2 (SNT-1) F9052 314850, 10818, 327826 Frs2,FRS2

XP725 Antibody List

114142 Foxp2,FOXP2 NP_683697.1,NP_997600.1 P y y y 285 FANCD2 F0305 2177 FANCD2 NP_149075.2 P y y y 286 FXR2 F1554 9513 FXR2 NP_004851.1 M y n/d n/d 287 FRS2 (SNT-1) F9052 314850, 10818, 327826 Frs2,FRS2